ArticleACS medicinal chemistry letters2018

Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases.

Michael R Michaelides et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.